Drug: TACROLIMUS. Injury: Renal impairment Quarter: 2016Q3
Total Records: 27 Number of Pages: 2
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 126892231 | TACROLIMUS. | Renal impairment | AMGEN | 47.00 YR | M | 0 | 20160826 | CA |
| 126900661 | TACROLIMUS. | Renal impairment | AMGEN | 51.00 YR | M | 0 | 20160826 | CA |
| 126977391 | TACROLIMUS. | Renal impairment | STRIDES | 0.00 | 0 | 20160830 | US | |
| 127028592 | TACROLIMUS. | Renal impairment | VIIV | 55.00 YR | M | 58 KG | 20160915 | CN |
| 127029652 | TACROLIMUS. | Renal impairment | GLAXOSMITHKLINE | 55.00 YR | M | 58 KG | 20160915 | CN |
| 127806411 | TACROLIMUS. | Renal impairment | SANDOZ | 67.00 YR | F | 0 | 20160926 | US |
| 127987971 | TACROLIMUS. | Renal impairment | APOTEX | 0.00 | F | 0 | 20160930 | US |
Total Records: 27 Number of Pages: 2